跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Augmentin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Augmentin
Approved
STANDARD
Augmentin
SmithKline Beecham Ltd. T/A SmithKline Beecham Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f8107ce71844431f
Company
SmithKline Beecham Ltd. T/A SmithKline Beecham Pharmaceuticals
Type
Standard
Approval Details
Approval Id
f8107ce71844431f
Drug Approval Philippines Name
Augmentin
Product Name
Augmentin
Registration Number
DR-XY24085
Brand Name
Augmentin
Generic Name
Co-Amoxiclav
Dosage Form
Powder For Suspension
Dosage Strength
228.5 mg per 5 mL
Manufacturer
SmithKline Beecham Ltd. T/A SmithKline Beecham Pharmaceuticals
Importer
GlaxoSmithKline Philippines, Inc.
Issuance Date
28 November 2022
Expiry Date
28 November 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f8107ce71844431f
Type
Standard
Back to Philippines FDA Approvals